“A choice of the future to reimagine medicine with health actors”
It was inaugurated today in Milan the new headquarters of the Swiss Novartis in Italy. The choice of the Lombard capital, in the Porta Garibaldi area, facilitates proximity to the institutions and the ecosystem of innovation and research, with the aim ‘reimagining’ the medicine of the futurereads a note released by the pharmaceutical company.
“This transfer represents a future-oriented choice for us. We are convinced that this is an important new chapter in our history, which will allow us to better interact with institutions and the medical-scientific community, actively contributing to the great health challenges. to create a new paradigm for the benefit of the community and patients “, he declares Valentino Confalone, Country President and CEO of Novartis Italia.
In Italy – underlines the company – Novartis is one of the largest companies in the pharmaceutical sector, with a leading role in the most important therapeutic areas (such as cardiovascular, immunology, onco-hematology and neuroscience), representing one of the first investors in Research & Developmentwith approximately 250 million investments expected by 2023. In 2021, Novartis contributed to the treatment of over 13 million patients in the country and generated an overall impact – on a social, environmental and economic level – of 8.4 billion euros.
The new headquarters also represents an opportunity to reinterpret the way of working, enhancing the potential of people in full respect of the reconciliation between private and working life. In September – the note recalls – the adoption of ‘Choice with responsibility’ was announced, a new model that provides maximum flexibility in the management of working hours and the possibility of choosing the best place to work, in the office or remotely, within a framework of equivalence of time spent inside and outside the company spaces. An innovative way of generating value and new ideas, which will allow us to respond more easily to the needs of the ecosystem, to redesign the health of the future together.
The Novartis Italia headquarters in Milan was built by Colliers Global Investors Italythe company that owns the entire property, in the name of sustainability, completely rethinking, from an architectural and construction point of view, an existing building and guaranteeing the best performance from the point of view of energy efficiency, demonstrated by the next achievement of the Leed Platinum certification, American classification system for the energy efficiency and ecological footprint of buildings.